Tempus AI vs Direxion Daily FTSE China Bull 3x Shares — how do they compare? Tempus AI trades at $55.7 (market cap $10.05B), while Direxion Daily FTSE China Bull 3x Shares trades at $29.29. Which is the better fit depends on your goals.
| TEM | YINN | |
|---|---|---|
Market Cap | $10.05B | — |
Sector | Broad Market / Factor | Leveraged / Inverse |
52-Week High | $103.25 | $56.62 |
52-Week Low | $41.55 | $21.45 |
Enterprise Value | $10.68B | — |
Signals from Pluang's Aura AI — not financial advice
Tempus AI (TEM) trades at $52.05, up 12.86% in 24 hours, reflecting strong momentum after Q2 2026 earnings beat revenue estimates and raised 2026 sales guidance. The stock is technically bullish with moving averages supporting upside, while fundamentals show revenue growth to $1.4 billion in 2026 but persistent net losses. Recent news highlights expansion through the Personalis acquisition and AI-driven precision medicine advancements.
Outlook: Growth prospects are robust with AI adoption in healthcare and strategic deals, but high valuation ratios and negative profitability pose risks. Analysts are bullish with a $61.57 consensus target, though cash burn and competitive pressures require monitoring for sustained investor confidence.
YINN (Direxion Daily FTSE China Bull 3x ETF) trades at $31.50, up 1.68% with a bullish technical signal. The ETF tracks Chinese equities, showing strength amid Hang Seng Index outperformance versus Asian peers. Moving averages signal bullish momentum while oscillators remain neutral. Recent news highlights China's AI investment plans and export growth, though regulatory tensions with the US persist.
Outlook remains cautiously optimistic given China's tech focus and infrastructure spending, but leveraged structure amplifies risks. Key risks include US-China trade tensions and China's economic stabilization efforts. Investors should weigh the ETF's 3x leverage against China's growth trajectory and regulatory environment.
Trailing returns across standard periods
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →YINN is a leveraged ETF that seeks daily investment results, before fees and expenses, of 300% (3x) of the daily performance of the FTSE China 50 Index. It is a tactical instrument designed for sophisticated traders seeking to magnify short-term bullish views on large-cap Chinese equities, primarily those trading on the Hong Kong Stock Exchange.
Read more on YINN →